Annji Pharmaceutical Co (ROCO:7754) 5-Year Share Buyback Ratio : 0.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Annji Pharmaceutical Co 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Annji Pharmaceutical Co's current 5-Year Share Buyback Ratio was 0.00%.

ROCO:7754's 5-Year Share Buyback Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: -9.7
* Ranked among companies with meaningful 5-Year Share Buyback Ratio only.

Competitive Comparison of Annji Pharmaceutical Co's 5-Year Share Buyback Ratio

For the Biotechnology subindustry, Annji Pharmaceutical Co's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annji Pharmaceutical Co's 5-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annji Pharmaceutical Co's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Annji Pharmaceutical Co's 5-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Annji Pharmaceutical Co 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Annji Pharmaceutical Co (ROCO:7754) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Annji Pharmaceutical Co 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Annji Pharmaceutical Co's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Annji Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » 5-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011

Website

https://www.ajpharm.com

Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.

Annji Pharmaceutical Co Headlines

No Headlines